Allena Pharmaceuticals Inc EV/EBIT
¿Qué es el EV/EBIT de Allena Pharmaceuticals Inc?
El EV/EBIT de Allena Pharmaceuticals Inc es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con Allena Pharmaceuticals Inc
Empresas con ev/ebit similar a Allena Pharmaceuticals Inc
- Hi Crush Inc tiene EV/EBIT de N/A
- Cocrystal Pharma Inc tiene EV/EBIT de N/A
- Panorama Capital tiene EV/EBIT de N/A
- Nuverra Environmental Solutions Inc tiene EV/EBIT de N/A
- Touchpoint tiene EV/EBIT de N/A
- Equity Metals tiene EV/EBIT de N/A
- Allena Pharmaceuticals Inc tiene EV/EBIT de N/A
- Queen's Road Capital Investment tiene EV/EBIT de N/A
- Uxin Ltd tiene EV/EBIT de N/A
- Red Light Holland tiene EV/EBIT de N/A
- St. James Gold tiene EV/EBIT de N/A
- Eat Beyond Global tiene EV/EBIT de N/A
- Consolidated Firstfund Capital tiene EV/EBIT de N/A